Mainz Issuance Of Capital Stock from 2010 to 2024

MYNZ Stock  USD 5.25  0.35  6.25%   
Mainz Biomed Issuance Of Capital Stock yearly trend continues to be fairly stable with very little volatility. Issuance Of Capital Stock is likely to outpace its year average in 2024. During the period from 2010 to 2024, Mainz Biomed Issuance Of Capital Stock regression line of annual values had r-squared of  0.39 and arithmetic mean of  3,308,949. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
6.4 M
Current Value
M
Quarterly Volatility
6.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.1 M or Interest Expense of 419.9 K, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0 or PTB Ratio of 6.09. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.
  
Check out the analysis of Mainz Biomed Correlation against competitors.

Latest Mainz Biomed's Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of Mainz Biomed BV over the last few years. It is Mainz Biomed's Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Slightly volatile
   Issuance Of Capital Stock   
       Timeline  

Mainz Issuance Of Capital Stock Regression Statistics

Arithmetic Mean3,308,949
Geometric Mean0.00
Coefficient Of Variation203.53
Mean Deviation4,853,125
Median0.00
Standard Deviation6,734,798
Sample Variance45.4T
Range23.9M
R-Value0.62
Mean Square Error30T
R-Squared0.39
Significance0.01
Slope935,856
Total Sum of Squares635T

Mainz Issuance Of Capital Stock History

2024M
20236.4 M
202223.9 M
202110.4 M

About Mainz Biomed Financial Statements

Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Issuance Of Capital Stock6.4 MM

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.